Joung, J
IV Glutathione Intravenous (IV) glutathione has gained popularity in "med-spas" for its purported skin-lightening and detoxing effects
Request specifically Thyroid panel: TSH, free T3, free T4 for baseline thyroid function Monitoring schedule during therapy The first year of GLP-1 therapy carries the highest deficiency risk
Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats
Extended-release formulations and enteric-coated drugs may perform unpredictably
It raises the possibility that these drugs may have broader anti-inflammatory or cardiometabolic effects, which is particularly interesting in a systemic inflammatory disease such as HS. According to Jastrzb-Mikiewicz, patients with HS are frequently diagnosed with obesity, insulin resistance, diabetes, and other metabolic comorbidities, making GLP-1s particularly relevant for this population